Clinical Trial

Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Efficacy and safety of short-course radiotherapy in total neoadjuvant therapy combined with enlonstobart for pMMR locally advanced rectal cancer
Protocol Amendment History 1 change
critical Recruitment opened 2026-08-01
Trial Details
NCT Number NCT07448077
Lead Sponsor Hebei Medical University Fourth Hospital
Conditions Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer
Enrollment 128 participants
Start Date 2026-03-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-31